<?xml version="1.0" encoding="UTF-8"?>
<ref id="B211-ijms-20-02167" class="ref">
 <label class="label">211.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Menendez</surname>
    <given-names class="given-names">J.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Vellon</surname>
    <given-names class="given-names">L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lupu</surname>
    <given-names class="given-names">R.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Antitumoral actions of the anti-obesity drug orlistat (Xenical
   <sup class="sup">TM</sup>) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
  </article-title>
  <source class="source">Ann. Oncol.</source>
  <year class="year">2005</year>
  <volume class="volume">16</volume>
  <fpage class="fpage">1253</fpage>
  <lpage class="lpage">1267</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1093/annonc/mdi239</pub-id>
  <?supplied-pmid 15870086?>
  <pub-id pub-id-type="pmid" class="pub-id">15870086</pub-id>
 </element-citation>
</ref>
